BridgeBio Pharma logo

Sr. Manager / Associate Director, QA Operations: CSP Oversight (Packaging) and Market Release

BridgeBio Pharma

San Francisco, CAHybridPosted 1 day ago$187,700 - $222,900/year
Full TimeDirector & AboveQuality (QA / QC)Biotechnology
Original posting ↗

Summary

The Sr. Manager / Associate Director, QA Operations supports finished product batch disposition and market release for the commercial portfolio of BridgeBio and its affiliates across the US, EU, and rest of world (ROW) markets. The role also provides quality oversight of the contract service providers (CSPs) responsible for commercial packaging, operating in a virtual, outsourced manufacturing model and working closely with CMC, Regulatory Affairs, and Supply Chain.

Job description

Responsibilities

Batch Disposition and Market Release

  • Own the market release process end to end, including finished product batch disposition and review of batch records, CSP documentation, and release testing results before disposition.
  • Serve as the primary point of contact for EU QPs, preparing batch documentation to support QP certification.
  • Maintain market specific release requirements and release status across US, EU, and ROW markets, in coordination with Regulatory Affairs and Supply Chain.
  • Support ex US market launches, including establishing market release processes and QP release workflows.

CSP and Partner Oversight

  • Provide quality oversight of packaging CSPs through remote collaboration, KPI monitoring, and adherence to quality agreements.
  • Interface with CSPs, third party logistics providers (3PLs), and other partners to align on quality expectations and drive continuous improvement.
  • Support internal and external audits and regulatory inspections related to CSP oversight and finished product disposition.

Quality Systems and Compliance

  • Author and review deviations, CAPA, change controls, risk assessments, and product investigations related to QA Operations and systems.
  • Support tech transfer, validation, and shipping qualification protocols and reports.
  • Support CMC activities, including review of regulatory submissions and post approval changes.
  • Author, review, and update QA Operations SOPs and other quality documents.
  • Contribute to the Annual Product Quality Review (APQR).
  • Identify, assess, and escalate quality or compliance issues to management.

Where You'll Work

This is a hybrid role and requires in-office collaboration 2-3x per week in our San Francisco Office.

Requirements

  • Bachelor's degree in a science discipline
  • 10+ years of experience in a biopharmaceutical company
  • Strong knowledge of US (21 CFR Parts 210, 211, and 11) and EU (Directive 2001/83/EC, EudraLex Volume 4 including Annex 16) regulations, plus ROW market release requirements
  • Hands-on market release experience, including direct interaction with QPs
  • Experience overseeing CSPs within a virtual or outsourced manufacturing and packaging network, coordinating across multiple external partners
  • Excellent communication skills across functions, with the ability to work directly with external QPs and CSPs and with internal Regulatory and Supply Chain teams
  • Experience supporting a new market launch, including establishing market release processes and QP release workflows
  • Experience with serialization and track and trace: the US Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (2011/62/EU and Delegated Regulation (EU) 2016/161)
  • Experience with quality systems such as Veeva Vault
  • Experience with label and artwork management systems (such as GLAMS)

Benefits

  • 401(k) Matching
  • Employee Stock Purchase Program
  • Pre-tax Commuter Benefits
  • Referral Bonus
  • Subsidized Lunch & Parking
  • Medical, Dental & Vision
  • Health Savings Account
  • Flexible Spending Accounts
  • Fertility & Family-Forming Benefits
  • Mental Health Support
  • Flexible Paid Time Off
  • Paid Medical & Parental Leave
  • Professional Development Programs

Company overview

BridgeBio Pharma is a pioneering biopharmaceutical company founded in 2015 with a mission to discover, create, test, and deliver transformative medicines for patients suffering from genetic diseases. Headquartered in Palo Alto, California, the company operates as a new type of biopharmaceutical organization that bridges the gap between remarkable advancements in genetic science and patients with unmet medical needs. BridgeBio focuses on Mendelian diseases, which arise from defects in a single gene, and cancers with clear genetic drivers. The company's innovative approach involves identifying and advancing promising scientific discoveries through a portfolio model that spans early discovery to late-stage development. With a pipeline of over 20 development programs, BridgeBio employs a team of experienced drug discoverers, developers, and innovators committed to applying advances in genetic medicine to help patients as quickly as possible. The company's business model combines scientific expertise with entrepreneurial execution to address rare genetic conditions that have historically been overlooked by traditional pharmaceutical companies due to small patient populations and industry reluctance to conduct early-stage development.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.